Demographic and evolutionary insights from whole-genome sequencing of Plasmodium falciparum in South America
New Voices in Infection Biology
- Cancelled
- Date: Jun 15, 2022
- Time: 04:00 PM (Local Time Germany)
- Speaker: Angela Early
- Broad Institute of MIT and Harvard
- Location: Zoom video conference
- Host: Silvia Portugal & Manuela Carrasquilla
- Contact: vseminars@mpiib-berlin.mpg.de

If you are interested in joining the seminar, please contact: vseminars@mpiib-berlin.mpg.de
Once registered, you will receive a zoom conference link 30 mins before the talk starts - please sign in using your full name.
Talk abstract:
Genomic diversity in Plasmodium falciparum has been undercharacterized in many parts of South America, considering the significance of local disease burden, challenges to disease elimination, and the propensity for de novo emergence of drug resistance mutations in this region. Growing efforts across the continent are now changing this. I will report on recent genomic data from French Guiana, Guyana, Colombia, and Ecuador that are rapidly expanding our understanding of how parasites evolve in the face of changing human migration patterns and newly imposed disease interventions. The joint analysis of these data sets demonstrates how genome-wide sequencing and targeted molecular surveillance across the Americas is increasing our ability to detect the early emergence of drug resistance, track regional parasite movement, and measure declines in diversity that could mark successful intervention strategies.Genomic diversity in Plasmodium falciparum has been undercharacterized in many parts of South America, considering the significance of local disease burden, challenges to disease elimination, and the propensity for de novo emergence of drug resistance mutations in this region. Growing efforts across the continent are now changing this. I will report on recent genomic data from French Guiana, Guyana, Colombia, and Ecuador that are rapidly expanding our understanding of how parasites evolve in the face of changing human migration patterns and newly imposed disease interventions. The joint analysis of these data sets demonstrates how genome-wide sequencing and targeted molecular surveillance across the Americas is increasing our ability to detect the early emergence of drug resistance, track regional parasite movement, and measure declines in diversity that could mark successful intervention strategies.